SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-008281
Filing Date
2023-11-17
Accepted
2023-11-17 16:05:45
Documents
61
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR SEPT 2023 cpmd_i10q-093023.htm   iXBRL 10-Q 810143
2 CERTIFICATION cannapharmarx_ex3101.htm EX-31.1 11435
3 CERTIFICATION cannapharmarx_ex3102.htm EX-31.2 11479
4 CERTIFICATION cannapharmarx_ex3200.htm EX-32 4526
  Complete submission text file 0001683168-23-008281.txt   3905837

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE cpmd-20230930.xsd EX-101.SCH 37727
6 XBRL CALCULATION FILE cpmd-20230930_cal.xml EX-101.CAL 56160
7 XBRL DEFINITION FILE cpmd-20230930_def.xml EX-101.DEF 112131
8 XBRL LABEL FILE cpmd-20230930_lab.xml EX-101.LAB 241312
9 XBRL PRESENTATION FILE cpmd-20230930_pre.xml EX-101.PRE 207312
55 EXTRACTED XBRL INSTANCE DOCUMENT cpmd_i10q-093023_htm.xml XML 483569
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27055 | Film No.: 231418614
SIC: 2834 Pharmaceutical Preparations